Surgimate Company Profile

Background

Overview

Surgimate is a New York-based company specializing in surgical scheduling software solutions. Founded in 2009, Surgimate has developed a platform that unifies data, surgeons, and support staff around a single source of truth, aiming to maximize surgical throughput and revenue.

Mission and Vision

Surgimate's mission is to streamline surgical operations by providing a comprehensive orchestration platform that enhances efficiency, reduces cancellations, and increases surgical volume. The company's vision is to transform surgical practices into predictable, scalable engines for growth and improved patient care.

Primary Area of Focus

Surgimate focuses on surgical scheduling and coordination, offering a platform that integrates various aspects of surgical operations, including scheduling, pre-operative requirements, and communication among surgical teams.

Industry Significance

In the healthcare technology sector, Surgimate plays a crucial role by addressing operational inefficiencies in surgical practices. By providing a unified platform, Surgimate helps practices increase surgical volume, reduce cancellations, and improve overall operational efficiency.

Key Strategic Focus

Core Objectives

Increase Surgical Throughput: Enhance the number of surgeries performed by optimizing scheduling and coordination processes.

Reduce Cancellations: Implement robust pre-operative protocols to minimize last-minute cancellations.

Maximize Block Utilization: Ensure efficient use of operating room time to boost revenue.

Specific Areas of Specialization

Surgimate specializes in surgical scheduling, pre-operative management, and communication facilitation among surgical teams. The platform is designed to integrate these areas into a cohesive workflow, enhancing overall surgical operations.

Key Technologies Utilized

Surgimate employs a cloud-based platform that integrates various surgical scheduling and coordination tools. The platform includes features such as automated form generation, real-time communication tools, and analytics dashboards to monitor and improve surgical operations.

Primary Markets or Conditions Targeted

Surgimate primarily targets surgical practices, including single-surgeon offices and large multi-surgeon groups, aiming to improve operational efficiency and patient care across various surgical specialties.

Financials and Funding

Funding History

Surgimate has raised funding through a venture equity round on September 20, 2022. The total amount raised and the lead investors for this round are not publicly disclosed.

Total Funds Raised

The exact total funds raised by Surgimate are not publicly disclosed.

Notable Investors

Banneker Partners is a known investor in Surgimate.

Intended Utilization of Capital

While specific details on the utilization of the capital raised are not publicly disclosed, it is likely that the funds are allocated towards product development, market expansion, and enhancing operational capabilities to support the company's growth objectives.

Pipeline Development

As a software company, Surgimate's pipeline development focuses on enhancing its surgical scheduling platform. The company continually updates its software to improve features such as automated form generation, real-time communication tools, and analytics dashboards. Specific timelines for these developments are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

Surgimate's proprietary technology includes a cloud-based platform that integrates various surgical scheduling and coordination tools, such as automated form generation and real-time communication features.

Significant Scientific Methods

The platform utilizes data integration and workflow automation to streamline surgical operations, though specific scientific methodologies are not detailed in the available information.

Leadership Team

Key Executive Profiles

Kraig Brown – Chief Executive Officer: With a background in healthcare technology, Kraig leads Surgimate's strategic direction and operations.

Alisa Vaughn – Chief Operating Officer: Alisa oversees daily operations, ensuring the company's services meet client needs effectively.

Stacy Kilgore – Chief Financial Officer: Stacy manages financial strategies, including budgeting, forecasting, and financial reporting.

Jessica Cook – Chief Revenue Officer: Jessica is responsible for driving revenue growth through strategic sales and marketing initiatives.

Bharath Perugu – Chief Product and Technology Officer: Bharath leads product development and technological innovation, ensuring the platform meets market demands.

Joseph Marino – President, openDoctor: Joseph oversees openDoctor, a subsidiary of Surgimate, focusing on expanding the company's service offerings.

Jeff Grabow – Executive Vice President, ImplantBase: Jeff leads ImplantBase, another subsidiary, contributing to Surgimate's growth and service diversification.

Leadership Changes

In March 2025, Surgimate acquired ImplantBase LLC, a company specializing in implant management solutions. This acquisition aims to enhance Surgimate's platform by integrating implant tracking and management capabilities, providing a more comprehensive solution for surgical practices.

Competitor Profile

Market Insights and Dynamics

The surgical scheduling software market is growing as healthcare providers seek to improve operational efficiency and patient care. Key trends include the adoption of cloud-based solutions, integration of artificial intelligence for predictive analytics, and the need for platforms that offer comprehensive surgical coordination.

Competitor Analysis

Surgimate faces competition from companies such as CaseCTRL, LeanTaaS, and LiveData, which offer similar surgical scheduling and coordination solutions. Each competitor provides unique features, but Surgimate differentiates itself through its comprehensive platform that integrates various aspects of surgical operations.

Strategic Collaborations and Partnerships

Surgimate's acquisition of ImplantBase LLC in March 2025 is a significant strategic move, enhancing its platform with implant management capabilities. This acquisition aims to provide a more integrated solution for surgical practices, addressing a broader range of operational needs.

Operational Insights

Surgimate's platform offers a unified solution for surgical scheduling and coordination, addressing common challenges such as cancellations, scheduling inefficiencies, and communication gaps among surgical teams. By integrating these functions, Surgimate enhances operational efficiency and supports the growth of surgical practices.

Strategic Opportunities and Future Directions

Surgimate's strategic roadmap includes expanding its platform's capabilities through acquisitions like ImplantBase LLC, enhancing its service offerings to meet the evolving needs of surgical practices. The company aims to continue innovating and providing solutions that improve surgical operations, positioning itself as a leader in surgical coordination software.